If you start eating a lot of vegetables, for instance, thats just as likely to result in gas as SIBO die-off
The most frequently reported side effects of tirzepatide are gastrointestinal in nature, consistent with the mechanism of action shared by GLP-1 receptor agonists
Recent findings suggest that modifying AhR-dependent signaling in the intestine may diminish cholesterol absorption facilitated by the GI cholesterol transporter Niemann-Pick C1-like 1 by inhibiting the transcriptional function of sterol regulatory element-binding protein-2 34
There have been studies showing GLP-1 medications improving cardiovascular health, cognitive health, [and] Recent research has also shown that GLP-1 drugs may be associated with improved breast cancer survival rates and reduced recurrence in people with obesity and related conditions
Errors in administration, though uncommon with pre-filled pens, can result in subtherapeutic dosing
Being trained in GI, nutrition and obesity medicine, I wanted to be able to offer my patients something in addition to lifestyle intervention and I knew this would be impactful. In an earlier case series published in the Journal of Pediatric Gastroenterology and Nutrition , Panganiban and colleagues reported that liraglutide (Saxenda/Victoza, Novo Nordisk), in conjunction with lifestyle intervention, was effective in inducing and maintaining weight loss and improve insulin sensitivity among pediatric patients with metabolic dysfunction-associated steatohepatitis, overweight/obesity and type 2 diabetes